Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Treasury Shares (2018 - 2025)

Health Catalyst (HCAT) has disclosed Treasury Shares for 8 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares changed N/A year-over-year to $5.1 million, compared with a TTM value of $5.1 million through Sep 2025, changed N/A, and an annual FY2024 reading of $524313.0, down 83.15% over the prior year.
  • Treasury Shares was $5.1 million for Q3 2025 at Health Catalyst, up from $1.1 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.1 million in Q3 2025 and bottomed at $145027.0 in Q1 2023.
  • Average Treasury Shares over 5 years is $1.8 million, with a median of $906370.0 recorded in 2022.
  • The sharpest move saw Treasury Shares surged 1160.74% in 2022, then crashed 96.53% in 2023.
  • Year by year, Treasury Shares stood at $2.3 million in 2021, then plummeted by 68.81% to $709139.0 in 2022, then soared by 338.78% to $3.1 million in 2023, then tumbled by 83.15% to $524313.0 in 2024, then soared by 870.44% to $5.1 million in 2025.
  • Business Quant data shows Treasury Shares for HCAT at $5.1 million in Q3 2025, $1.1 million in Q2 2025, and $2.7 million in Q1 2025.